Moreover, both patients with GD1, characterized by reduced GCase activity and high substrate levels in visceral organs but not in the brain, and asymptomatic carriers of a single GBA1 mutation, who have some reduced GCase level and little or no substrate elevation, exhibit similar PD risks [28]. The gene discussed is GBA1; the disease is Parkinson disease.